Zunqiang Xiao

Zhejiang Provincial People's Hospital

Papers

1

Total Citations

2

H-Index

1

About

Dr. Zunqiang Xiao is a leading hepatobiliary surgeon whose research focuses on advancing minimally invasive surgical techniques for hepatocellular carcinoma (HCC). His major contribution lies in rigorously comparing the safety and efficacy of laparoscopic versus robotic complex hepatectomy, particularly through large-scale, multicenter studies. His most-cited work, a 2024 propensity score-matched analysis, demonstrates his commitment to evidence-based surgery, providing critical data that helps guide clinical decision-making for solitary HCC. This study, already garnering 2 citations shortly after publication, underscores the growing interest in his findings. Dr. Xiao’s research directly addresses the pressing need to optimize perioperative outcomes in complex liver surgery, offering insights that reduce morbidity and improve patient recovery. By leveraging advanced statistical methods to control for selection bias, his work stands as a benchmark for future comparative effectiveness research in surgical oncology. For students and researchers in hepatobiliary surgery, Dr. Xiao’s portfolio exemplifies how rigorous methodology can illuminate the nuanced benefits of robotic versus laparoscopic approaches, shaping the future of minimally invasive liver resection.

Research Focus

Key Achievements

1
H-Index
1
Papers
2
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
Multicenter Propensity Score-Matched Analysis to Compare Perioperative Morbidity After Laparoscopic or RoboticComplex Hepatectomy for Solitary Hepatocellular Carcinoma
2 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 19
🏛 Institutions: Zhejiang Provincial People's Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago